PDF
ePub
Citation
Print
Abstract
Breast MRI is the most accurate adjunctive to the mammography for the screening of breast cancer. Despite lack of randomized controlled trials on the effectiveness of MRI screening, it is now recommended for the women at high risk for breast cancer by the American Cancer Society and the National Comprehensive Cancer Network based on several prospective observational studies. In Korea, a retrospective study reported that preoperative MRI screening of the contralateral breast in women with unilateral breast cancer was associated with reduced metachronous cancer incidence. To introduce breast MRI as a supplemental modality to screening mammography in Korea, standardization and education of interpretation, establishment of MR-guided biopsy and adequate indication, and evaluation of cost-effectiveness and should be preceded.
References
1. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011. 1:CD001877.
2. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003. 361:1411–1417.
3. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005. 353:1773–1783.
4. Kuhl CK. The "coming of age" of nonmammographic screening for breast cancer. JAMA. 2008. 299:2203–2205.
5. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound. Cancer. 1995. 76:626–630.
6. Buchberger W, Niehoff A, Obrist A, DeKoekkoek-Doll M, Dunser M. Clinically and mammographically occult breast lesions: detection and classifi cation with high-resolution sonography. Semin Ultrasound CT MR. 2000. 21:325–336.
7. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001. 221:641–649.
8. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that infl uence them: an analysis of 27,825 patient evaluations. Radiology. 2002. 225:165–175.
9. Youk JH, Kim EK. Current Trends in Breast Ultrasonography. J Korean Soc Ultrasound Med. 2012. 31:1–10.
10. Shin HJ, Kim HH, Cha JH. Automated Breast Ultrasound. J Korean Soc Ultrasound Med. 2011. 30:157–162.
11. Kim HS, Kang BJ, Lee JH, et al. Sensitivity and Specificity of Screening Mammographies and Ultrasonographies Performed in Women at Seven Health Promotion Centers for One year. J Korean Soc Ultrasound Med. 2010. 29:1–5.
12. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008. 299:2151–2163.
13. Feig SA. Feig SA, editor. Current status of screening US. 2005 Syllabus: categorical course in diagnostic radiology-breast imaging. 2005. Oak Brook, IL: Radiological Society of North America;143–154.
14. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012. 307:1394–1404.
15. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004. 183:1149–1157.
16. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008. 148:671–679.
17. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004. 292:1317–1325.
18. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004. 351:427–437.
19. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005. 365:1769–1778.
20. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005. 23:8469–8476.
21. Hagen AI, Kvistad KA, Maehle L, et al. Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast. 2007. 16:367–374.
22. Riedl CC, Ponhold L, Flöry D, et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res. 2007. 13:6144–6152.
23. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007. 356:1295–1303.
24. Sickles EA. The use of breast imaging to screen women at high risk for cancer. Radiol Clin N Am. 2010. 48:859–878.
25. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007. 57:75–89.
26. Lehman CD, Smith RA. The role of MRI in breast cancer screening. J Natl Compr Canc Netw. 2009. 7:1109–1115.
27. Kim JY, Cho N, Moon WK. Bilateral preoperative MR examinations in newly diagnosed breast cancer patients: initial and long-term impact on contralateral breast cancer diagnosis. Programs and abstracts of the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago.
XML Download